RTTR - Ritter Pharmaceuticals Inc.
Previous close
0.448
0.448 100.000%
Share volume: 0
Last Updated: Fri 22 May 2020 10:00:00 PM CEST
Pharmaceuticals: Other:
0%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
Summary score
40%
Profitability
50%
Dept financing
39%
Liquidity
34%
Performance
31%
Sector
Health Technology
Industry
Pharmaceuticals: Other
Long-term ratios 2016 - 2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-300.12%
Return on assets
-42.46%
Return on sales
0%
Return on invested capital
136.36%
Total debt ratio
41.8%
Debt ratio change over timeo
-0.57%
Current Ratio
4.57%
Quick Ratio
0%
Cash Position Ratio
4.13%
Short-term ratios 2019 - 2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-912.61%
Return on assets
-50.56%
Return on sales
0%
Return on invested capital
94.37%
Total debt ratio
60.23%
Debt ratio change over timeo
-0.31%
Current Ratio
1.91%
Quick Ratio
0%
Cash Position Ratio
1.7%
Last quarter ratios 2020
The data are presented for the financials results of the last quarter.
Return on equity
-33.25%
Return on assets
-33.12%
Return on sales
0%
Return on invested capital
149.61%
Total debt ratio
25.01%
Debt ratio change over time
-0.38%
Current Ratio
3.67%
Quick Ratio
0%
Cash Position Ratio
3.56%
Performance ratios (change over 4 years) 2016 - 2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-401.84%
Return on assets
-142.31%
Return on sales
0%
Return on invested capital
29.46%
Total debt ratio
-57.4%
Debt ratio change over time
-0.57%
Current Ratio
2.78%
Quick Ratio
0%
Cash Position Ratio
2.59%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | RTTR | MYOK | MDCO | ARQL |
|---|---|---|---|---|
| Return on equity | -300.12% | -7.13% | -82.7% | -27.35% |
| Return on assets | -42.46% | -6.36% | -6.39% | -11.35% |
| Return on sales | 0% | 0% | -592.81% | 0% |
| Return on invested capital | 136.36% | -84.69% | -39.78% | 65.52% |
| Profitability | 50% | 50% | 0% | 12% |
| Total debt ratio | 41.8% | 15.45% | 89.22% | 38.11% |
| Debt ratio change over time | -0.57% | -0.99% | -8.16% | -0.59% |
| Dept financing | 37% | 4% | 25% | 11% |
| Current Ratio | 1.91% | 11.45% | 3.37% | 10.41% |
| Quick Ratio | 0% | 0% | 0% | 0% |
| Cash Position Ratio | 1.7% | 6.31% | 2.81% | 5.11% |
| Liquididy | 30% | 50% | 42% | 28% |
| Short-term ratios | RTTR | MYOK | MDCO | ARQL |
|---|---|---|---|---|
| Return on equity | -912.61% | -13.67% | -16.61% | -6.32% |
| Return on assets | -50.56% | -12.16% | -6.02% | -5.59% |
| Return on sales | 0% | 0% | 0% | 0% |
| Return on invested capital | 94.37% | 4.61% | -30.98% | 34.2% |
| Profitability | 50% | 1% | 0% | 59% |
| Total debt ratio | 60.23% | 12.33% | 101.32% | 14.38% |
| Debt ratio change over time | -0.31% | -1.02% | -9.66% | -0.83% |
| Dept financing | 40% | 3% | 25% | 4% |
| Current Ratio | 1.91% | 11.45% | 3.37% | 10.41% |
| Quick Ratio | 0% | 0% | 0% | 0% |
| Cash Position Ratio | 1.7% | 6.31% | 2.81% | 5.11% |
| Liquididy | 36% | 50% | 18% | 43% |